SEC Form 4 · accession 0000899243-16-021505
REGENXBIO Inc. · RGNX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Camille D Samuels
Director
Period of report
Jun 1, 2016
Accepted (ET)
Jun 2, 2016 · 5:00 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001590877
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2,F1 | $12.74 | Jun 1, 2016 | A | 12,500 | A | — | Jun 1, 2026 | Common Stock | 12,500 | 12,500 | D |
Explanation of responses
- F1The option will vest in twelve (12) equal monthly installments following June 1, 2016.
- F2Under an agreement between the reporting person and VR Management, LLC (the "Management Company"), the reporting person is deemed to hold the reported securities for the sole benefit of the Management Company. The Management Company may be deemed the indirect beneficial owner of the reported securities, and the reporting person may be deemed the indirect beneficial owner of the reported securities through her interest in the Management Company. The reporting person disclaims beneficial ownership of the reported securities except to the extent of her pecuniary interest therein.